Form 4: Edwards Lifesciences SVP, Corporate Controller, Robert W.A. Sellers, Reports Stock Disposal

Robert W.A. Sellers, SVP, Corporate Controller at Edwards Lifesciences, reported the disposal of 229 shares of common stock at a price of $86.72 on May 11, 2024.

Summary

• On May 11, 2024, Robert W.A. Sellers, SVP, Corporate Controller at Edwards Lifesciences Corp, disposed of 229 shares of common stock.
• The transaction was executed at a price of $86.72 per share.
• Following the transaction, Sellers directly owns 17,081.198 shares and indirectly owns 20,409 shares through a trust.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of a stock transaction by a company insider. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their insiders, ensuring compliance with SEC regulations.
• Similar filings are made by executives at comparable companies like Medtronic and Abbott Laboratories when they engage in stock transactions.

Stakeholder Impact

• The transaction may have a minor impact on shareholders as it reflects an insider's decision to sell a small portion of their holdings.

Key Dates